Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
transplantation. Blood, 2024. 143(11): p. 953-966. Yoshizato T. et al., Stable contribution of lineage-restricted stem cells to steady-state human haematopoiesis. Nature Genetics, 2025. Doi: https://doi.org/10.1038
-
level, and institution level. The doctoral student project and the duties of the doctoral student We are looking for a highly motivated PhD student with an interest in B-cell biology and B cell related
-
validation of these models using human induced pluripotent stem cells (hiPSCs). In collaboration with members of the OMBION consortium, you will further expand our systems to include relevant pain-associated
-
) or PhD (for PostDoc) in stem cell biology, developmental biology, biophysics, or related fields Strong expertise in pluripotent stem cell culture and differentiation protocols Practical experience with
-
organoid-based research. For more information go to: https://www.bauschlab.org Your Qualification: High motivation, curiosity, and commitment to scientific excellence PhD in stem cell biology, developmental
-
for Hematology and Regenerative Medicine (HERM) at the Department of Medicine, Huddinge , is seeking a highly motivated PhD student to use pluripotent stem cells for studying human hematopoiesis and modeling
-
At the laboratory of Associate Professor Kumar Somyajit, we seek a highly motivated PhD student with strong background in cell biology and prime interest in cell cycle, genome maintenance, cancer
-
-activated cell sorting (FACS), and immunoprecipitation (IP). Maintains and differentiates human induced pluripotent stem cells (iPSCs) into specific cell lineages using established protocols and assist with
-
Fixed-term: The funds for this post in the first instance is are available for 12 months. The Cambridge Stem Cell Institute is an international centre of excellence for stem cell research and
-
university hospitals in Western France) Follow-up of allogeneic stem cell transplant patients Thrombophilia testing (Factor V Leiden, Prothrombin G20210A mutation) In 2024, laboratory activity exceeded 9,000